Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
After finishing at $59.50 in the prior trading day, Doximity Inc (NYSE: DOCS) closed at $58.45, down -1.76%. In other words, the price has decreased by -$1.76 from its previous closing price. On the day, 5.86 million shares were traded.
Ratios:
Our goal is to gain a better understanding of DOCS by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.98 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 47.26. For the most recent quarter (mrq), Quick Ratio is recorded 8.67 and its Current Ratio is at 8.67. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on February 07, 2025, Upgraded its rating to Overweight and sets its target price to $78 from $31 previously.
On February 07, 2025, Leerink Partners Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $60 to $90.
On December 20, 2024, Stephens started tracking the stock assigning a Equal-Weight rating and target price of $55.Stephens initiated its Equal-Weight rating on December 20, 2024, with a $55 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 01 ’25 when Wampler Kira Scherer sold 2,000 shares for $56.93 per share. The transaction valued at 113,853 led to the insider holds 16,618 shares of the business.
Bryson Anna sold 50,000 shares of DOCS for $3,000,000 on May 02 ’25. The Chief Financial Officer now owns 357,165 shares after completing the transaction at $60.00 per share. On May 01 ’25, another insider, Bryson Anna, who serves as the Chief Financial Officer of the company, sold 45,000 shares for $57.23 each. As a result, the insider received 2,575,235 and left with 357,165 shares of the company.
Valuation Measures:
As of this moment, Doximity’s Price-to-Earnings (P/E) ratio for their current fiscal year is 58.34, and their Forward P/E ratio for the next fiscal year is 36.22. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 6.04. For the stock, the TTM Price-to-Sale (P/S) ratio is 19.93 while its Price-to-Book (P/B) ratio in mrq is 10.63.
Stock Price History:
Over the past 52 weeks, DOCS has reached a high of $85.21, while it has fallen to a 52-week low of $23.27. The 50-Day Moving Average of the stock is 0.38%, while the 200-Day Moving Average is calculated to be 13.62%.
Shares Statistics:
A total of 133.45M shares are outstanding, with a floating share count of 129.05M. Insiders hold about 31.23% of the company’s shares, while institutions hold 66.56% stake in the company.
